Usage: FEMLYV is indicated for females of reproductive potential to prevent pregnancy. Its efficacy in individuals with a body mass index over 35 kg/m² has not been assessed.
Usage: INTRAROSA® is indicated for the treatment of moderate to severe dyspareunia, which is a symptom of vulvar and vaginal atrophy due to menopause.